Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463060
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463060
Tardive Dyskinesia Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug (Deutetrabenazine, Valbenazine, and Others); By Product Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global tardive dyskinesia therapeutics market size is expected to reach USD 5.57 billion by 2032, according to a new study by Polaris Market Research. The report "Tardive Dyskinesia Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug (Deutetrabenazine, Valbenazine, and Others); By Product Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The drastic increase in the prevalence of various neurological and psychotic disorders and growing need for disease-specific novel treatment, are the leading factors propelling market's growth. Additionally, increase in financial support to the researchers and health institutes for advancing the novel intervention and bring innovations in the healthcare sector including therapeutics for tardive dyskinesia, are further anticipated to drive market's growth.
For instance, in November 2023, Neurocrine Biosciences, introduced DISCOVER TD, which is an interactive digital tool specially designed to help healthcare providers learn and identify about the tardive dyskinesia. Tool is built in collaboration with the clinical experts.
The rising cases of mental illnesses across the globe which requires prolonged treatment with antipsychotic drugs that causes irregular dopamine, fostering the demand for effective therapeutics. Also, the growing adoption of neuropsychological testing for monitoring or detecting changes in cognitive function, identifying specific patterns, and speed of information processing, are also propelling the market's growth. For instance, as per a report by the Centers for Disease Control and Prevention, nearly 1 in 5 US adults live with some form of mental illness, & nearly1 in 5 youth have seriously debilitating mental illness during their life.
Furthermore, the guideline of the American Academy of Neurology was updated recently for incorporating 2 FDA-approved VMAT2 inhibitors including valbenazine & deutetrabenazine, which has been marked as a huge milestone because they had undergone multi-center, randomized, & double-blind clinical trials. They were the first one which is going to be supported by the level A evidence and were mainly approved for the treatment of tardive dyskinesia in the United States.
Tardive Dyskinesia Therapeutics Market Report Highlights
Valbenazine segment accounted for the noteworthy share, on account of rising number of awareness campaigns about such diseases and their therapeutics
Solid dosage form segment held the majority share, driven by its rising adoption by healthcare professionals and higher effectiveness of medication
Online pharmacies segment will grow at highest pace, due to rising number of online buyers and emergence of several online pharmacies for the remotest places
North America dominated the global market, owing to region's greater awareness about disease and wider availability of treatment options, coupled with positive reimbursement scenario
The key market players include Reddy Laboratories, SOM Biotech, Luye Pharma Group, Prestwick Pharmaceuticals, Sun Pharmaceuticals Industries, and Allergan
Polaris Market Research has segmented the tardive dyskinesia therapeutics market report based on drug, product type, distribution channel, and region:
Tardive Dyskinesia Therapeutics, Drug Outlook (Revenue - USD Billion, 2019 - 2032)
- Deutetrabenazine
- Valbenazine
- Others
Tardive Dyskinesia Therapeutics, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Solid Dosage Forms
- Tablets
- Capsules
- Liquid Dosage Form
- Injection
Tardive Dyskinesia Therapeutics, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
- Others
Tardive Dyskinesia Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4423
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Tardive Dyskinesia Therapeutics Market Insights
- 4.1. Tardive Dyskinesia Therapeutics Market - Distribution Channel Snapshot
- 4.2. Tardive Dyskinesia Therapeutics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Research and Development Initiatives.
- 4.2.1.2. Increasing prevalence of tardive dyskinesia and focus of companies on gaining product approvals are propelling market growth.
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited Understanding of Pathophysiology
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Tardive Dyskinesia Therapeutics Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Tardive Dyskinesia Therapeutics Market, by Drug
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 5.3. Deutetrabenazine
- 5.3.1. Global Tardive Dyskinesia Therapeutics Market, by Deutetrabenazine, by Region, 2019-2032 (USD Billion)
- 5.4. Valbenazine
- 5.4.1. Global Tardive Dyskinesia Therapeutics Market, by Valbenazine, by Region, 2019-2032 (USD Billion)
- 5.5. Others
- 5.5.1. Global Tardive Dyskinesia Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Tardive Dyskinesia Therapeutics Market, by Product Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 6.3. Solid Dosage Form
- 6.3.1. Global Tardive Dyskinesia Therapeutics Market, by Solid Dosage Form, by Region, 2019-2032 (USD Billion)
- 6.4. Tablets
- 6.4.1. Global Tardive Dyskinesia Therapeutics Market, by Tablets, by Region, 2019-2032 (USD Billion)
- 6.5. Capsules
- 6.5.1. Global Tardive Dyskinesia Therapeutics Market, by Capsules, by Region, 2019-2032 (USD Billion)
- 6.6. Liquid Dosage Form
- 6.6.1. Global Tardive Dyskinesia Therapeutics Market, by Liquid Dosage Form, by Region, 2019-2032 (USD Billion)
- 6.7. Injection
- 6.7.1. Global Tardive Dyskinesia Therapeutics Market, by Injection, by Region, 2019-2032 (USD Billion)
7. Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Hospitals Pharmacies
- 7.3.1. Global Tardive Dyskinesia Therapeutics Market, by Hospitals Pharmacies, By Region, 2019-2032 (USD Billion)
- 7.4. Drug Stores & Retail Pharmacies
- 7.4.1. Global Tardive Dyskinesia Therapeutics Market, by Drug Stores & Retail Pharmacies, By Region, 2019-2032 (USD Billion)
- 7.5. Online Pharmacies
- 7.5.1. Global Tardive Dyskinesia Therapeutics Market, by Online Pharmacies, By Region, 2019-2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Tardive Dyskinesia Therapeutics Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Tardive Dyskinesia Therapeutics Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Tardive Dyskinesia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Tardive Dyskinesia Therapeutics Market - North America
- 8.3.1. North America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.3.2. North America: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.3. North America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.3.4. Tardive Dyskinesia Therapeutics Market - U.S.
- 8.3.4.1. U.S.: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.3.5. Tardive Dyskinesia Therapeutics Market - Canada
- 8.3.5.1. Canada: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4. Tardive Dyskinesia Therapeutics Market - Europe
- 8.4.1. Europe: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.3. Europe: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.4. Tardive Dyskinesia Therapeutics Market - UK
- 8.4.4.1. UK: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.5. Tardive Dyskinesia Therapeutics Market - France
- 8.4.5.1. France: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5.3. France: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.6. Tardive Dyskinesia Therapeutics Market - Germany
- 8.4.6.1. Germany: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.7. Tardive Dyskinesia Therapeutics Market - Italy
- 8.4.7.1. Italy: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.8. Tardive Dyskinesia Therapeutics Market - Spain
- 8.4.8.1. Spain: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.9. Tardive Dyskinesia Therapeutics Market - Netherlands
- 8.4.9.1. Netherlands: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.10. Tardive Dyskinesia Therapeutics Market - Russia
- 8.4.10.1. Russia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5. Tardive Dyskinesia Therapeutics Market - Asia Pacific
- 8.5.1. Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.4. Tardive Dyskinesia Therapeutics Market - China
- 8.5.4.1. China: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4.3. China: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.5. Tardive Dyskinesia Therapeutics Market - India
- 8.5.5.1. India: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5.3. India: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.6. Tardive Dyskinesia Therapeutics Market - Malaysia
- 8.5.6.1. Malaysia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.7. Tardive Dyskinesia Therapeutics Market - Japan
- 8.5.7.1. Japan: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.8. Tardive Dyskinesia Therapeutics Market - Indonesia
- 8.5.8.1. Indonesia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.9. Tardive Dyskinesia Therapeutics Market - South Korea
- 8.5.9.1. South Korea: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.6. Tardive Dyskinesia Therapeutics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.4. Tardive Dyskinesia Therapeutics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.5. Tardive Dyskinesia Therapeutics Market - UAE
- 8.6.5.1. UAE: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.6. Tardive Dyskinesia Therapeutics Market - Israel
- 8.6.6.1. Israel: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.7. Tardive Dyskinesia Therapeutics Market - South Africa
- 8.6.7.1. South Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.7. Tardive Dyskinesia Therapeutics Market - Latin America
- 8.7.1. Latin America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.4. Tardive Dyskinesia Therapeutics Market - Mexico
- 8.7.4.1. Mexico: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.5. Tardive Dyskinesia Therapeutics Market - Brazil
- 8.7.5.1. Brazil: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.6. Tardive Dyskinesia Therapeutics Market - Argentina
- 8.7.6.1. Argentina: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Allergan
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Contera Pharma
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Johnson & Johnson Services Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Lannett Co. Inc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Luye Pharma Group
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Mitsubishi Tanabe Pharma Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Neurocrine Biosciences Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Prestwick Pharmaceuticals Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Reddy Laboratories Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. SOM Biotech
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. SteriMax Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Sun Pharmaceutical Industries Ltd.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Teva Pharmaceutical Industries Ltd.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Valeant Pharmaceuticals
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
Product Code: PM4423
List of Tables
- Table 1 Global Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 2 Global Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 3 Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 4 Tardive Dyskinesia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 6 North America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 7 North America: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 8 U.S.: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 9 U.S.: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 10 U.S.: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 11 Canada: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 12 Canada: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 13 Canada: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 14 Europe: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 15 Europe: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 16 Europe: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 17 UK: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 18 UK: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 19 UK: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 20 France: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 21 France: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 22 France: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 23 Germany: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 24 Germany: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 25 Germany: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 26 Italy: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 27 Italy: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 28 Italy: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 29 Spain: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 30 Spain: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 31 Spain: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 32 Netherlands: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 33 Netherlands: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 34 Netherlands: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 35 Russia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 36 Russia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 37 Russia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 41 China: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 42 China: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 43 China: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 44 India: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 45 India: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 46 India: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 47 Malaysia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 48 Malaysia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 49 Malaysia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 50 Japan: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 51 Japan: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 52 Japan: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 53 Indonesia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 54 Indonesia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 55 Indonesia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 56 South Korea: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 57 South Korea: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 58 South Korea: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 65 UAE: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 66 UAE: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 67 UAE: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 68 Israel: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 69 Israel: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 70 Israel: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 71 South Africa: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 72 South Africa: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 73 South Africa: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 74 Latin America: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 75 Latin America: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 76 Latin America: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 77 Mexico: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 78 Mexico: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 79 Mexico: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 80 Brazil: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 81 Brazil: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 82 Brazil: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 83 Argentina: Tardive Dyskinesia Therapeutics Market, by Drug, 2019-2032 (USD Billion)
- Table 84 Argentina: Tardive Dyskinesia Therapeutics Market, by Product Type, 2019-2032 (USD Billion)
- Table 85 Argentina: Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Tardive Dyskinesia Therapeutics Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Product Type
- Figure 7. Global Tardive Dyskinesia Therapeutics Market, by Product Type, 2022 & 2032 (USD Billion)
- Figure 8. Market by Drug
- Figure 9. Global Tardive Dyskinesia Therapeutics Market, by Drug, 2022 & 2032 (USD Billion)
- Figure 10. Market by Distribution Channel
- Figure 11. Global Tardive Dyskinesia Therapeutics Market, by Distribution Channel, 2022 & 2032 (USD Billion)
- Figure 12. Tardive Dyskinesia Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Tardive Dyskinesia Therapeutics Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.